Literatur
- 1
van den Akker-van Marle M E, Bruil J, Detmar S B.
Evaluation of cost of disease: assessing the burden to society of asthma in children
in the European Union.
Allergy.
2005;
60
140-149
- 2
Bisgaard H, Hermansen M N, Loland L, Halkjaer L B, Buchvald F.
Intermittent inhaled corticosteroids in infants with episodic wheezing.
N Engl J Med.
2006;
354
1998-2005
- 3
Bergmann R L, Bergmann K E, Lau-Schadendorf S, Luck W, Dannemann A, Bauer C P, Dorsch W,
Forster J, Schmidt E, Schulz J, Wahn U.
Atopic diseases in infancy. The German multicenter atopy study (MAS-90).
Pediatr Allergy Immunol.
1994;
5 (Suppl1)
19-25
- 4
Illi S, von Mutius E, Lau S, Niggemann B, Grüber C, Wahn U. Multicentre Allergy Study
(MAS) Group .
Perennial allergen sensitisation early in life and chronic asthma in children: a birth
cohort study.
Lancet.
2006;
368
763-770
- 5
Wahn U, Lau S, Bergmann R, Kulig M, Forster J, Bergmann K, Bauer C-P, Guggenmoos-Holzmann I.
Indoor allergen exposure is a risk factor for sensitization during the first three
years of life.
J Allergy Clin Immunol.
1997;
99
763-769
- 6
Lau S, Illi S, Sommerfeld C, Niggemann B, Bergmann R, von Mutius E, Wahn U.
Early exposure to house-dust mite and cat allergens and development of childhood asthma:
a cohort study.
Lancet.
2000;
356
1392-1397
- 7
Morgan W J, Stern D A, Sherrill D L, Guerra S, Holberg C J, Guilbert T W, Taussig L M,
Wright A L, Martinez F D.
Outcome of Asthma and Wheezing in the First 6 Years of Life: Follow-up through Adolescence.
Am J Respir Crit Care Med.
2005;
172
1253-1258
- 8
Sears M R, Greene J M, Willan A R, Wiecek E M, Taylor D R, Flannery E M, Cowan J O,
Herbison G P, Silva P A, Poulton R.
A longitudinal, population-based, cohort study of childhood asthma followed to adulthood.
N Engl J Med.
2003;
349
1414-1422
- 9
Phelan P D, Robertson C F, Olinsky A.
The Melbourne Asthma Study: 1964 – 1999.
J Allergy Clin Immunol.
2002;
109
189-194
- 10
Chen Y Z, Busse W W, Pedersen S, Tan W, Lamm C J, O'Byrne P M.
Early intervention of recent onset mild persistent asthma in children aged under 11
yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial.
Pediatr Allergy Immunol.
2006;
17 (Suppl 17)
7-13
- 11
Håland G, Carlsen K C, Sandvik L, Devulapalli C S, Munthe-Kaas M C, Pettersen M, Carlsen K H.
Reduced lung function at birth and the risk of asthma at 10 years of age.
N Engl J Med.
2006;
355
1682ff
- 12
Fedorov I A, Wilson S J, Davies D E, Holgate S T.
Epithelial stress and structural remodelling in childhood asthma.
Thorax.
2005;
60
389-394
- 13
Saglani S, Malmstrom K, Pelkonen A S, Malmberg L P, Lindahl H, Kajosaari M, Turpeinen M,
Rogers A V, Payne D N, Bush A, Haahtela T, Makela M J, Jeffery P K.
Airway remodeling and inflammation in symptomatic infants with reversible airflow
obstruction.
Am J Respir Crit Care Med.
2005;
171
722-727
- 14
Bisgaard H, Pedersen S, Anhoj J, Hedlin G, Gulsvik A, Bjermer L, Carlsen K H, Nordvall L,
Lundbäck B, Wennergren G, Werner S, Bonnelykke K, Weiss S T.
Determinants of lung function and airway hyperresponsiveness in asthmatic children.
Respir Med.
2007;
101
1477-1482
- 15
Holt P G, Sly P D, Martinez F D, Weiss S T, Bjorksten B, von Mutius E, Wahn U.
Drug development strategies for asthma: in search of a new paradigm.
Nat Immunol.
2004;
5
695-698
- 16 The Global Initiative for Asthma .GINA Guidelines: Workshop Report, Global Strategy
for Asthma Management and Prevention, updated 2005. http://www.ginasthma.com/GuidelinesResources.asp December .20.2005
- 17
Bacharier L B, Boner A, Carlsen K H, Eigenmann P A, Frischer T, Götz M, Helms P J,
Hunt J, Liu A, Papadopoulos N, Platts-Mills T, Pohunek P, Simons F E, Valovirta E,
Wahn U, Wildhaber J. European Pediatric Asthma Group .
Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report.
Allergy.
2008;
63
5-34 Review
- 18
The Childhood Asthma Management Program Research Group .
Longterm effects of budesonide or nedocromil in children with asthma.
N Engl J Med.
2000;
343
1054-1063
- 19
Whelan G J, Blumer J L, Martin R J, Szefler S J.
Fluticasone propionate plasma concentration and systemic effect: effect of delivery
advice and duration of administration.
J Allergy Clin Immunol.
2005;
116
525-530
- 20
Szefler S J, Phillips B R, Martinez F D, Chinchilli V M, Lemanske R F, Strunk R C,
Zeiger R S. et al .
Characterization of within-subject responses to fluticasone and montelukast in childhood
asthma.
J Allergy and Clin Immunol.
2005;
115
233-242
- 21
Guilbert T W, Morgan W J, Zeiger R S, Mauger D T, Boehmer S J, Szefler S J, Bacharier L B,
Lemanske Jr R F, Strunk R C, Allen D B, Bloomberg G R, Heldt G, Krawiec M, Larsen G,
Liu A H, Chinchilli V M, Sorkness C A, Taussig L M, Martinez F D.
Long-term inhaled corticosteroids in preschool children at high risk for asthma.
N Engl J Med.
2006;
354
1985-1997
- 22
Pauwels R A, Busse W W, O"Byrne P M, Pedersen S, Tan W C, Chen Y Z, Ohlson S V, Ullman A.
The inhaled Steroid Treatment as Regular Therapy in early asthma (START) study: rationale
and design.
Control Clin Trials.
2001;
22
405-419
- 23
O'Byrne P M, Pedersen S, Busse W W, Tan W C, Chen Y Z, Ohlsson S V, Ullman A, Lamm C J,
Pauwels R A.
Effects of early intervention with inhaled budesonide on lung function in newly diagnosed
asthma.
Chest.
2006;
129
1405-1406
- 24
Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Wahn U.
Reducing domestic exposure of dust mite allergen reduces bronchial hyperreactivity
in sensitive asthmatic children.
J Allergy Clin Immunol.
1992;
90
135-138
- 25
Busse W, Corren J, Lanier B, McAlary M, Fowler-Taylor A, Della Cioppa G. et al .
Omalizumab, a anti-IgE recombinant humanized monoclonal antibody, for the treatment
of severe allergic asthma.
J Allergy Clin Immunol.
2001;
108
184-190
Priv.-Doz. Dr. med. Susanne Lau
Charité Campus Virchow
Klinik für Pädiatrie mit Schwerpunkt Pneumologie und Immunologie
Augustenburger Platz 1
13353 Berlin
eMail: susanne.lau@charite.de